Authors: SUNDLOF S

Citation: S. Sundlof, INTRODUCTORY-REMARKS FOR THE 1996 NRSP-7 WORKSHOP, Veterinary and human toxicology, 40, 1998, pp. 2-3

Authors: WEBB A MARSHALL B CRAIGMILL A SUNDLOF S LUTHER L BEAULIEU A

Citation: A. Webb et al., 8TH NRSP-7 FDA WORKSHOP - DRUG AVAILABILITY FOR MINOR SPECIES IN THE 21ST-CENTURY - SMALL RUMINANTS QUESTIONS/, Veterinary and human toxicology, 40, 1998, pp. 18-18

Authors: RINGER R MANN C BLACKWELL M MACFARLANE B GLOYD J SUNDLOF S PITTS J MILLER L HAFS H VAUGHN S WILKERSON J WEBBER N CARNEVALE R ZIMBELMAN R LUTHER L SUTHERLAND S WEBB A

Citation: R. Ringer et al., 8TH NRSP-7 FDA WORKSHOP - DRUG AVAILABILITY FOR MINOR SPECIES IN THE 21ST-CENTURY - PANEL DISCUSSION/, Veterinary and human toxicology, 40, 1998, pp. 54-62

Authors: KUNKLE GA SUNDLOF S KEISLING K

Citation: Ga. Kunkle et al., ADVERSE SIDE-EFFECTS OF ORAL ANTIBACTERIAL THERAPY IN DOGS AND CATS -AN EPIDEMIOLOGIC-STUDY OF PET OWNERS OBSERVATIONS, The Journal of the American Animal Hospital Association, 31(1), 1995, pp. 46-55

Authors: POWERS TE SUNDLOF S RITTER L GUEST G POWERS T JENKINS W BRUNTON J ZELLER M MACOMBER LE CLARK J LOEW F REID J MCCARTHY J JOHNSON G BRUMBAUGH G JOHNSON DE

Citation: Te. Powers et al., USE OF FDA-APPROVED DRUGS IN VETERINARY-MEDICINE - PROHIBITIONS, PREROGATIVES, AND RESPONSIBILITIES .1., Journal of the American Veterinary Medical Association, 202(10), 1993, pp. 1626-1631

Authors: POWERS T GEYER RE REID J SUNDLOF S WILKES D BOOTHE D TESKE RH BRUMBAUGH G BROWN S ADAMS JB LEIN D SWANSON R

Citation: T. Powers et al., IMPLICATIONS FOR THE FDA CENTER FOR VETERINARY-MEDICINE (CVM) - QUESTIONS AND ANSWERS, Journal of the American Veterinary Medical Association, 202(10), 1993, pp. 1720-1723